Human papillomavirus screening: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) No edit summary |
Aysha Aslam (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{Human papillomavirus}} | {{Human papillomavirus}} | ||
==Overview== | ==Overview== | ||
==Screening== | ==Screening== | ||
According to the US Preventive Services Task Force (USPSTF), screening guidelines for human papillomavirus infection leading to cervical cancer is described below: | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:51, 12 October 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
|
Human papillomavirus Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Human papillomavirus screening On the Web |
|
American Roentgen Ray Society Images of Human papillomavirus screening |
|
Risk calculators and risk factors for Human papillomavirus screening |
Overview
Screening
According to the US Preventive Services Task Force (USPSTF), screening guidelines for human papillomavirus infection leading to cervical cancer is described below: